UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Interleukin 12 a key immunoregulatory cytokine in infection applications

International Journal of Molecular Sciences, 2010-02, Vol.11 (3), p.789-806

2010

Volltextzugriff (PDF)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

BMC immunology, 2021-03, Vol.22 (1), p.23-16, Article 23

2021

Volltextzugriff (PDF)

Structure of the full-length Clostridium difficile toxin B

Nature structural & molecular biology, 2019-08, Vol.26 (8), p.712

2019

Volltextzugriff (PDF)

Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota

Nature communications, 2018-12, Vol.9 (1), p.5233-11, Article 5233

2018

Volltextzugriff (PDF)

Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection

BMC microbiology, 2014-07, Vol.14 (1), p.207-207, Article 207

2014

Volltextzugriff (PDF)

Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides

Biochemical and biophysical research communications, 2015-04, Vol.459 (2), p.259-263

2015

Volltextzugriff (PDF)

Delivery of a therapeutic antibody to the lower gastrointestinal tract for the treatment of Clostridium difficile infection (CDI)

Pharmaceutical development and technology, 2023-02, Vol.28 (2), p.232-239

2023

Volltextzugriff (PDF)

Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes

Inflammatory bowel diseases, 2018-02, Vol.24 (3), p.573-582

2018

Volltextzugriff (PDF)

Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab

Infection and immunity, 2015-02, Vol.83 (2), p.822-831

2015

Volltextzugriff (PDF)

Nanoparticles targeting to osteoblasts for potential intracellular pathogen elimination

Journal of controlled release, 2015-09, Vol.213, p.e10-e11

2015

Volltextzugriff (PDF)

Unique Antimicrobial Effects of Platelet-Rich Plasma and Its Efficacy as a Prophylaxis to Prevent Implant-Associated Spinal Infection

Advanced healthcare materials, 2013-09, Vol.2 (9), p.1277-1284

2013

Volltextzugriff (PDF)

The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model

Anaerobe, 2017-12, Vol.48, p.249-256

2017

Volltextzugriff (PDF)

A novel co-culture model of murine K12 osteosarcoma cells and S. aureus on common orthopedic implant materials: 'the race to the surface' studied in vitro

Biofouling (Chur, Switzerland), 2016-07, Vol.32 (6), p.627-634

2016

Volltextzugriff (PDF)

Defective mutations within the translocation domain of Clostridium difficile toxin B impair disease pathogenesis

Pathogens and disease, 2016-02, Vol.74 (1), p.ftv098-ftv098

2016

Volltextzugriff (PDF)

Intra-cellular Staphylococcus aureus alone causes infection in vivo

European cells & materials, 2013-07, Vol.25, p.341-50; discussion 350

2013

Volltextzugriff (PDF)

Infection Models of Intracellular Staphylococcus aureus and The Impact of Interleukin 12 on Macrophage Killing Activity

Hamza, Therwa

2012

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)
Dissertationen
(1)

Sprache

Englisch
(17)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interleukin 12 a key immunoregulatory cytokine in infection applications

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

Structure of the full-length Clostridium difficile toxin B

Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota

Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection

Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants

Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides

Delivery of a therapeutic antibody to the lower gastrointestinal tract for the treatment of Clostridium difficile infection (CDI)

Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes

Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab

Nanoparticles targeting to osteoblasts for potential intracellular pathogen elimination

Unique Antimicrobial Effects of Platelet-Rich Plasma and Its Efficacy as a Prophylaxis to Prevent Implant-Associated Spinal Infection

The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model

A novel co-culture model of murine K12 osteosarcoma cells and S. aureus on common orthopedic implant materials: 'the race to the surface' studied in vitro

Defective mutations within the translocation domain of Clostridium difficile toxin B impair disease pathogenesis

Intra-cellular Staphylococcus aureus alone causes infection in vivo

Infection Models of Intracellular Staphylococcus aureus and The Impact of Interleukin 12 on Macrophage Killing Activity

Suchergebnisse filtern